Ind Swift Laboratories Intrinsic Value
Ind Swift Laboratories intrinsic value. Ind Swift Laboratories (INDSWFTLAB) median intrinsic value is ₹159.28 from 8 valuation models (range ₹116–₹318), vs current price ₹385.75 — -58.7% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with INDSWFTLAB stock valuation models to assess whether the stock is under or overvalued.
INDSWFTLAB Valuation Methods Summary — DCF, Graham Number & P/E
Ind Swift Laboratories intrinsic value across 8 models vs current price ₹385.75 — upside/downside and value range per method. Read INDSWFTLAB dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹159.28 | ₹127.42 - ₹191.14 | -58.7% | EPS: ₹7.24, Sector P/E: 22x |
| Book Value Method | asset | ₹318.16 | ₹286.34 - ₹349.98 | -17.5% | Book Value/Share: ₹159.08, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹158.16 | ₹142.34 - ₹173.98 | -59.0% | Revenue/Share: ₹79.08, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹154.30 | ₹138.87 - ₹169.73 | -60.0% | EBITDA: ₹72.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹304.45 | ₹243.56 - ₹365.34 | -21.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹115.72 | ₹104.15 - ₹127.29 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹115.72 | ₹104.15 - ₹127.29 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹160.98 | ₹144.88 - ₹177.08 | -58.3% | EPS: ₹7.24, BVPS: ₹159.08 |
INDSWFTLAB Intrinsic Value vs Market Price — All Valuation Models
Ind Swift Laboratories fair value range ₹116–₹318 vs current market price ₹385.75 across 8 valuation models. For current market price and key ratios, visit INDSWFTLAB screener.
INDSWFTLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Ind Swift Laboratories median intrinsic value ₹159.28, current price ₹385.75 — Trading Above Calculated Value by 58.7%, margin of safety -100.0%.
What is the intrinsic value of INDSWFTLAB?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Ind Swift Laboratories (INDSWFTLAB) is ₹159.28 (median value). With the current market price of ₹385.75, this represents a -58.7% variance from our estimated fair value.
The valuation range spans from ₹115.72 to ₹318.16, indicating ₹115.72 - ₹318.16.
Is INDSWFTLAB undervalued or overvalued?
Based on our multi-method analysis, Ind Swift Laboratories (INDSWFTLAB) appears to be trading above calculated value by approximately 58.7%.
INDSWFTLAB Financial Health — Key Ratios vs Industry Benchmarks
Ind Swift Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 30.53 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.41x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
INDSWFTLAB Cash Flow Quality — Operating & Free Cash Flow
Ind Swift Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-68 Cr | ₹-103 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-29 Cr | ₹-86 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-163 Cr | ₹-215 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹195 Cr | ₹189 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹150 Cr | ₹150 Cr | Positive Free Cash Flow | 8/10 |